Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bicyclol for Chronic Hepatitis C Genotype 1 (Observational Case Series)
ChiCTR-OPh-17011456Phase 4Recruiting
- Sponsor
- The Second Hospital of Nanjing
- Start
- Apr 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of bicyclol in hepatitis C virus infection, sponsored by The Second Hospital of Nanjing. Primary endpoints: HCV RNA examination, HCV RNA examination (duplicate listing) and 1 more. Started Apr 2016; status: recruiting.
02
Drugs
bicyclol
03
Conditions
hepatitis C virus infection
Beyond the preview
Go deeper on ChiCTR-OPh-17011456.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-OPh-17011456.